Assessment of the Efficacy and Safety of a Combination of 2 Topical Retinoids (RetinSphere) in Maintaining Post-Treatment Response of Acne to Oral Isotretinoin

Orozco, 2011, Guías colombianas para el manejo del acne: una revisión basada en la evidencia por el Grupo Colombiano de Estudio en Acne, Rev Asoc Colomb Dermatol, 19, 129 Agarwal, 2011, Oral isotretinoin in different dose regimens for acne vulgaris: a randomized comparative trial, Indian J Dermatol Venereol Leprol, 77, 688, 10.4103/0378-6323.86482 Borghi, 2011, Low-cumulative dose isotretinoin treatment in mild-to-moderate acne: efficacy in achieving stable remission, J Eur Acad Dermatol Venereol, 25, 1094, 10.1111/j.1468-3083.2010.03933.x Straus, 1984, Isotretinoin therapy for acne: results of a multicenter dose-response study, J Am Acad Dermatol, 10, 490, 10.1016/S0190-9622(84)80100-0 Blasiak, 2013, High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris, JAMA Dermatol, 149, 1392, 10.1001/jamadermatol.2013.6746 Coloe, 2011, Could higher doses of isotretinoin reduce the frequency of treatment failure in patients with acne?, J Am Acad Dermatol, 65, 422, 10.1016/j.jaad.2010.06.025 Morales-Cardona, 2013, Acne relapse rate and predictors of relapse following treatment with oral isotretinoin, Actas Dermosifiliogr, 104, 61, 10.1016/j.ad.2012.05.004 Azoulay, 2007, Isotretinoin therapy and the incidence of acne relapse: a nested case-control study, Br J Dermatol, 157, 1240, 10.1111/j.1365-2133.2007.08250.x Thiboutot, 2009, New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group, J Am Acad Dermatol, 60, S1, 10.1016/j.jaad.2009.01.019 Zane, 2006, Acne maintenance therapy: expanding the role of topical retinoids?, Arch Dermatol, 142, 638, 10.1001/archderm.142.5.638 Bettoli, 2013, Maintenance therapy for acne vulgaris: efficacy of a 12-month treatment with adapalene-benzoyl peroxide after oral isotretinoin and a review of the literature, Dermatology, 227, 97, 10.1159/000350820 Vender, 2012, Double-blinded, vehicle-controlled proof of concept study to investigate the recurrence of inflammatory and noninflammatory acne lesions using tretinoin gel (microsphere) 0.04% in male patients after oral isotretinoin use, Dermatol Res Pract, 2012, 736532, 10.1155/2012/736532 Guidance for Industry Acne Vulgaris: Developing Drugs for Treatment. 2005J:\GUIDANC\6499dftcln3.doc. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). September 2005. Clinical/Medical. Krejci-Manwaring, 2006, Social sensitivity and acne: the role of personality in negative social consequences and quality of life, Int J Psychiatry Med, 36, 121, 10.2190/FQXN-K610-BNY8-UQ0L Cyrulnik, 2012, High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life, Int J Dermatol, 51, 1123, 10.1111/j.1365-4632.2011.05409.x Saple, 2004, An open study to evaluate the efficacy and safety of tazarotene gel (0.1%) in acné vulgaris, Indian J Dermatol Venereol Leprol, 70, 92 Quereux, 2006, Prospective study of risk factors of relapse after treatment of acne with oral isotretinoin, Dermatology, 212, 168, 10.1159/000090658 Fernandez-Vozmedian, 2003, Retinoides en dermatología, Med Cutan Iber Lat Am, 31, 271 Elson, 1998, The role of retinoids in wound healing, J Am Acad Dermatol, 39, S79, 10.1016/S0190-9622(98)70450-5 Jones, 2005, The potential immunomodulatory effects of topical retinoids (review), Dermatol Online J, 11, 3, 10.5070/D394Q2X8F1 Fabbrocini, 2012, Valutazione dell’eficacia dell’associazione di due retinoidi nel trattamento dell’acne lieve-moderata, Esper Dermatol, 14, 1 Veraldi, 2012, Treatment of comedonal-papular mild acne with a fixed combination of hydroxypinacolone retinoate, retinol glycospheres and papain glycospheres. Preliminary results of a sponsor-free, pilot, open multicentre study, Eur J Acne Relat Dis, 3, 13 DATA ON FILE 2008: TOPICAL HYDROXYPINACOLONE RETINOATE Skin Diffusion, Receptor Activity, Metabolism and Mildness. John Gormley. Grant Industries Inc. 2008.